☰
Top Menu
Doctors
Locations
About
Articles/News
Contact
Patient Portal
Make a Payment
Healthcare Questions
RX Questions: 844-683-6443
Regional Cancer Care Associates
Call 844-346-7222
Contact Us
Search for:
☰
Main Menu
Navigating Care
Getting Started
Cancer Types
Clinical Trials
Cancer Care Support
Oncology Medical Home
Patient & Caregiver Education
Services
Side Effects Management
Telemedicine
Cancer Types
Bladder Cancer
Brain Cancer
Breast Cancer
Cervical Cancer
Colon Cancer
Esophageal Cancer
Fallopian Tube Cancer
Head & Neck Cancer
Kidney Cancer
Leukemia
Liver Cancer
Lung Cancer
Lymphoma
Mesothelioma
Multiple Myeloma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Rectal Cancer
Skin Cancer
Stomach Cancer
Testicular Cancer
Thyroid Cancer
Uterine Cancer
Services
Active Surveillance
Blood & Marrow
Chemotherapy
Clinical Trials
Cryotherapy
Genetic Testing
Hematology
Hospital Consultation
Integrative Care
Immunotherapy
Palliative Care
Radiation Therapy
Radiosurgery
Surgery
Targeted Therapy
Pharmacy
Clinical Trials
All Clinical Trials
For Providers
Care Coordination
Imaging Guidelines
Oncology Medical Home
Advocacy
Advocacy Articles / News
Financial Advocacy
Patient Advocacy
Clinical Trials
Ibrutinib and Venetoclax in Relapsed and Refractory Follicular Lymphoma
March 15, 2018
